INJECTION SITE DISCHARGE

This adverse event was reported 5383 times

These drugs are most commonly taken by patients reporting INJECTION SITE DISCHARGE:

# Drug Count
0 ADALIMUMAB 939
1 TREPROSTINIL 484
2 SOMATROPIN 354
3 RISANKIZUMAB-RZAA 234
4 ORAL SEMAGLUTIDE 222
5 DUPILUMAB 206
6 TADALAFIL 174
7 AMBRISENTAN 164
8 VEDOLIZUMAB 154
9 LENACAPAVIR SODIUM 149
See all common drugs associated with INJECTION SITE DISCHARGE

INJECTION SITE DISCHARGE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Adrenocorticotropic Hormone [EPC] 117 0.1307
1 Recombinant Human Growth Hormone [EPC] 222 0.0101
2 Interleukin-5 Antagonist [EPC] 5 0.0073
3 Endoglycosidase [EPC] 11 0.0059
4 Interferon alfa-2b [EPC] 11 0.0059
5 Sucrose-specific Enzyme [EPC] 1 0.0055
6 Human Immunoglobulin G [EPC] 101 0.0048
7 Provitamin D2 Compound [EPC] 120 0.0040
8 Guanylate Cyclase-C Agonist [EPC] 8 0.0039
9 Prostacycline Vasodilator [EPC] 486 0.0035
See all drug classes enriched for association with INJECTION SITE DISCHARGE